chr14-23559987-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_003917.5(AP1G2):c.2207G>A(p.Arg736Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000299 in 1,613,004 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_003917.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP1G2 | NM_003917.5 | c.2207G>A | p.Arg736Gln | missense_variant | 21/22 | ENST00000397120.8 | NP_003908.1 | |
THTPA | NM_024328.6 | c.*1147C>T | 3_prime_UTR_variant | 2/2 | ENST00000288014.7 | NP_077304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP1G2 | ENST00000397120.8 | c.2207G>A | p.Arg736Gln | missense_variant | 21/22 | 1 | NM_003917.5 | ENSP00000380309 | P1 | |
THTPA | ENST00000288014.7 | c.*1147C>T | 3_prime_UTR_variant | 2/2 | 1 | NM_024328.6 | ENSP00000288014 | P1 | ||
ZFHX2-AS1 | ENST00000553985.1 | n.1531C>T | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000421 AC: 64AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000418 AC: 104AN: 248784Hom.: 1 AF XY: 0.000416 AC XY: 56AN XY: 134722
GnomAD4 exome AF: 0.000288 AC: 421AN: 1460718Hom.: 2 Cov.: 30 AF XY: 0.000308 AC XY: 224AN XY: 726634
GnomAD4 genome AF: 0.000407 AC: 62AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74486
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at